Drugs | Pts n. | RR | CR/PR | Authors |
---|---|---|---|---|
G 1,000 mg/m2 | 7 | 0 % | 0/0 | Merimsky O, Sarcoma 2000 [13] |
G 675 mg/m2 D 75–100 mg/m2 | 10 | 30 % | 0/3 | Navid F, Cancer 2008 [14] |
G 900 mg/m2 D 80–100 mg/m2 | 14 | 7 % | 0/1 | Fox E. SARC 003, Oncologist 2010 [15] |
G 675 mg/m2 ± D 75–100 mg/m2 | 4 | 25 % | 0/1 | Gosiengfiao Y, J Pediatr Hematol Oncol 2012 [16] |
G 675 mg/m2 + D 75–100 mg/m2 | 18 | 5 % | 0/1 | Qi WX, Jpn J Clin Oncol 2012 [17] |
G 675–900 mg/m2 D 100 mg/m2 | 17 | 24 % | 3/1 | Song BS, Pediatr Blood Cancer 2014 [18] |